<SEC-DOCUMENT>0001104659-23-024366.txt : 20230222
<SEC-HEADER>0001104659-23-024366.hdr.sgml : 20230222
<ACCEPTANCE-DATETIME>20230222172735
ACCESSION NUMBER:		0001104659-23-024366
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230222
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230222
DATE AS OF CHANGE:		20230222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMICUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001178879
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200422823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33497
		FILM NUMBER:		23654733

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		(215) 921-7600

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMICUS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm237622d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:fold="http://amicustherapeutics.com/20230222">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_fold_amicustherapeutics.com_20230222 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20230222_20230222 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001178879 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityCentralIndexKey">0001178879</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fold-20230222.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-02-22to2023-02-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178879</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-22</xbrli:startDate>
        <xbrli:endDate>2023-02-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>UNITED
STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>WASHINGTON,
D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b></b>&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20230222__20230222_zRlilcVpIsMf"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>CURRENT
REPORT PURSUANT TO</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECTION
13 OR 15(d) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Date of Report (Date of
earliest event reported):&#160;<b><span id="xdx_906_edei--DocumentPeriodEndDate_c20230222__20230222_zVoIwm9IiiG3"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February 22, 2023</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20230222__20230222_zKaTtMZFlq22"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityRegistrantName">AMICUS THERAPEUTICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Exact
Name of Registrant as Specified in  Its Charter)</p>

<p style="font-size: 10pt; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%; border-collapse: collapse; text-align: left">
<tr style="vertical-align: bottom">
    <td style="padding: 2px; text-align: center; width: 32%"><b><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20230222__20230222_znfyqo1mqaf"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></td>
    <td style="padding: 2px; text-align: left; width: 2%"><b>&#160;</b></td>
    <td style="padding: 2px; text-align: center; width: 32%"><span id="xdx_901_edei--EntityFileNumber_c20230222__20230222_zq7yTiK44da8" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityFileNumber">001-33497</ix:nonNumeric></span></td>
    <td style="padding: 2px; text-align: left; width: 2%"><b>&#160;</b></td>
    <td style="padding: 2px; text-align: center; width: 32%"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20230222__20230222_zT5rYQTYPCEg" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityTaxIdentificationNumber">71-0869350</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>(State
                                            or Other Jurisdiction</b></span></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>of Incorporation)</b></span></p></td>
    <td style="padding: 2px; text-align: center"><span style="font-style: normal"><b>&#160;</b></span></td>
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>(Commission</b></span></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>File Number)</b></span></p></td>
    <td style="padding: 2px; text-align: center"><span style="font-style: normal"><b>&#160;</b></span></td>
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>(I.R.S.
                                            Employer</b></span></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>Identification No.)</b></span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 192px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_901_edei--EntityAddressAddressLine1_c20230222__20230222_zCw0oZ1w8EMi"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityAddressAddressLine1">3675 Market Street</ix:nonNumeric></span>,
<span id="xdx_900_edei--EntityAddressCityOrTown_c20230222__20230222_zEobFaX5lCbc"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityAddressCityOrTown">Philadelphia</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20230222__20230222_zsHbp4a4mkti"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20230222__20230222_zoEafTdSi0E3"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:EntityAddressPostalZipCode">19104</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(Address of Principal
Executive Offices, and Zip Code)</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90E_edei--CityAreaCode_c20230222__20230222_zmYEsDHL6JYa"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:CityAreaCode">215</ix:nonNumeric></span>-<span id="xdx_909_edei--LocalPhoneNumber_c20230222__20230222_zEGplseewnEh"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:LocalPhoneNumber">921-7600</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Registrant&#8217;s
Telephone Number, Including Area Code</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report.)</p>

<p style="font-size: 10pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-left: 0.5in; font-size: 10pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20230222__20230222_ze9IKxFGmynl"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90F_edei--SolicitingMaterial_c20230222__20230222_z1SV5ASW34bb"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementTenderOffer_c20230222__20230222_zcH8d5ePpKvj"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20230222__20230222_zswzmaJeikKi"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant
to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%; border-collapse: collapse; text-align: left">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2px; padding-right: 2px; padding-left: 2px; text-align: center; width: 32%"><span style="font: normal 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 2%"><span style="font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 2px; padding-right: 2px; padding-left: 2px; text-align: center; width: 32%"><span style="font: normal 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 2%"><span style="font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 2px; padding-right: 2px; padding-left: 2px; text-align: center; width: 32%"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Times New Roman, Times, Serif">Name
                                            of each exchange on which registered</span></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--Security12bTitle_c20230222__20230222_zv5nvaG39Bv2"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:Security12bTitle">Common Stock Par Value $0.01</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--TradingSymbol_c20230222__20230222_zw5jifd9Ald7"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" name="dei:TradingSymbol">FOLD</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--SecurityExchangeName_c20230222__20230222_zdRlH17T8fWk"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR &#167;240.12b-2). Emerging growth company <span id="xdx_903_edei--EntityEmergingGrowthCompany_c20230222__20230222_znzXZ5Pwe0M9" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2023-02-22to2023-02-22" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></p>

<p style="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Item 7.01 &#8211; Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">On February 22, 2023, Amicus Therapeutics, Inc.
(the &#8220;Company&#8221;) issued a press release announcing positive long-term data from its Phase 3 open-label extension study of AT-GAA
in late-onset Pompe disease. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The information in this Item 7.01, including Exhibit
99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Act, or otherwise subject to the
liabilities of that Section. The information in this Item 7.01, including Exhibit 99.1, shall not be incorporated by reference into any
registration statement or other document pursuant to the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>(d) Exhibits:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 24%; padding-top: 3.75pt; padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 74%; padding-top: 3.75pt; padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; padding-top: 2.75pt; padding-bottom: 1.5pt; text-align: center"><a href="tm237622d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; padding-top: 2.75pt; padding-bottom: 1.5pt"><a href="tm237622d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">February 22, 2023 Press Release</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 2.75pt; padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="padding-top: 3.75pt; padding-bottom: 1.5pt"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration: underline">Signature Page</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: center; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 0.25in">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 10pt">AMICUS THERAPEUTICS, INC.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%"><span style="font-size: 10pt">Date: February 22, 2023</span></td>
    <td style="width: 3%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; width: 47%"><span style="font-size: 10pt">/s/
    Ellen S. Rosenberg</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 10pt">Name: Ellen S. Rosenberg</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 10pt">Title: Chief Legal Officer and Corporate
    Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk0KovbRokWsIkXE19iuEmyzZRP/juQtjS3isrAsM9+MEAOR0dLUyHCcFznssWlr7REKPCOjLTE40tU6gXALvBjnWVvfvT8wpcBgYMZDeSqD0FnvxmGVgJyO5GSkZiBniVKw24joq6dkz6ZC642uQdsKdkwtG/SaX33CXj/JUvPqqg7IzpBNQA1lL78hliqGLd31g/jqIM9TEQ26iUTGdGu/NTfnqYFFjU3ocj363+gDPyxJhA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm237622d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-size: 10pt; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font-size: 10pt; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt"><IMG SRC="tm237622d1_ex99-1img001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #232A31; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 10pt"><B>Amicus
Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th
Annual WORLD<I>Symposium</I>&#8482; 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>Meaningful
and Durable Responses in Key Endpoints of Six-Minute Walk, Forced Vital Capacity for ERT-Na&iuml;ve and ERT-Experienced Participants
Out to Two Years</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>Consistent
Reduction in Biomarkers Continue to Suggest a Positive Effect on Muscle Tissue; </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>Including
Participants who Switched from alglucosidase alfa to AT-GAA in the Open-label Extension </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I>Safety Profile
Aligns with Previously Reported Data</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>PHILADELPHIA,
PA, February 22, 2023</B> &#8211; <U>Amicus Therapeutics</U> (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused
on developing and commercializing novel medicines for rare diseases, today announced positive results from the global Phase 3 open-label
extension (OLE) study (ATB200-07) to investigate the long-term efficacy and safety of AT-GAA in adult patients with late-onset Pompe
disease, an inherited lysosomal disorder caused by an enzyme deficiency that leads to the accumulation of glycogen in cells. <FONT STYLE="color: #212529">Study
participants treated with AT-GAA for up to 104 weeks showed persistent and durable effects on six-minute walk distance (6MWD), stability
in forced vital capacity (FVC), and continued reductions in biomarkers of muscle damage and disease substrate.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><FONT STYLE="font-size: 10pt">These
clinical results are being featured at the 19th Annual WORLD<I>Symposium</I>&#8482; 2023 in a poster presentation and an oral platform
presentation scheduled for Sunday, February 26, 2023, at 9:00 a.m. ET. The presentation will be given by Benedikt Schoser, MD, Department
of Neurology, Ludwig-Maximilians-University of Munich and Principal Investigator in the PROPEL study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><FONT STYLE="font-size: 10pt">Bradley
Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc., stated, &#8220;These open-label extension data from our
Phase 3 PROPEL study of AT-GAA continue to represent meaningful and durable improvements in functional outcomes, as well as persistent
reductions in key biomarkers of muscle damage and disease substrate out to two years. These results give great hope that AT-GAA has the
potential to become the new global standard of care for people living with late-onset Pompe disease.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><FONT STYLE="font-size: 10pt">Dr.
Schoser stated, &#8220;There remains a need for new treatment options to address multiple facets of the Pompe disease spectrum, including
previously untreated and ERT-experienced patients living with Pompe disease. Consistent with the Phase 1/2 study and the Phase 3 PROPEL
study results, these first long-term results suggest that AT-GAA treatment for up to two years was associated with a durable effect.
This new data set could support a long-term treatment benefit in people with late-onset Pompe disease.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><FONT STYLE="font-size: 10pt"><B>ATB200-07
Study Data Highlights in ERT-experienced and ERT-na&iuml;ve Patients Out to Week 104</B> (n=118) Long-term follow-up data up to 104
weeks were presented for ERT-experienced patients (n=90) and ERT-na&iuml;ve patients (n=28).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 20px"></TD><TD STYLE="width: 20px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Motor
function (% predicted 6MWD):</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top"><TD STYLE="width: 60px"></TD><TD STYLE="width: 20px">&#9675;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ERT-experienced
and -na&iuml;ve patients treated with AT-GAA in the PROPEL study showed durable mean improvements in percent predicted six-minute walk
distance (6MWD) from baseline that were sustained through 104 weeks of follow-up.</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 60px"></TD><TD STYLE="width: 20px">&#9675;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ERT-experienced
and -na&iuml;ve patients who received alglucosidase alfa/placebo in PROPEL and switched to AT-GAA in the OLE showed stability in percent
predicted 6MWD throughout the OLE.</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 20px"></TD><TD STYLE="width: 20px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Pulmonary
Function (sitting % predicted FVC):</B></FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 60px"></TD><TD STYLE="width: 20px">&#9675;</TD><TD><FONT STYLE="font-size: 10pt">Pulmonary
function remained stable in participants throughout the OLE.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 60px"></TD><TD STYLE="width: 20px">&#9675;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ERT-experienced
patients treated with AT-GAA throughout remained stable, while patients who received alglucosidase alfa/placebo in PROPEL experienced
a decline in sitting % predicted forced vital capacity (FVC) that stabilized after switching to AT-GAA in the OLE.</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 60px"></TD><TD STYLE="width: 20px">&#9675;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ERT-na&iuml;ve
patients in both treatment groups experienced some decline in FVC during the controlled portion of PROPEL that stabilized in the OLE
to week 104.</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="vertical-align: top"><TD STYLE="width: 20px"></TD><TD STYLE="width: 20px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Biomarker
(Serum CK and Urine Hex4):</B></FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Durable
                                            reductions in key biomarkers of muscle damage (creatine kinase or CK) and disease substrate
                                            (urine hexose tetrasaccharide or Hex4) across participants treated with AT-GAA for 104 weeks
                                            continue to suggest a positive effect on muscle tissue.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">ERT-experienced
                                            and -na&iuml;ve patients who received alglucosidase alfa/placebo in PROPEL showed a slight
                                            increase or stability in serum CK levels to week 52, and a marked decline after switching
                                            to AT-GAA in the OLE.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">ERT&#45;experienced
                                            patients who received alglucosidase alfa/placebo in PROPEL experienced an increase in Hex4
                                            and a marked decline after switching to AT-GAA in the OLE.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">ERT-na&iuml;ve
                                            patients experienced a decline in Hex4 levels during PROPEL in both treatment groups that
                                            stabilized or declined further during the OLE to week 104.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 20px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safety</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
                                            safety profile was similar for patients who continued AT-GAA treatment from the start of
                                            PROPEL and those who switched from alglucosidase alfa/placebo.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Most
                                            treatment emergent adverse events were mild to moderate in severity.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; color: #212529"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 60px"></TD><TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">No
                                            new safety signals were identified during the open label extension study.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>About AT-GAA</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">AT-GAA is a two-component
therapy that consists of cipaglucosidase alfa, a bis-M6P-enriched rhGAA which facilitates high-affinity uptake through the M6P receptor
while retaining its capacity for processing into the most active form of the enzyme, and the oral enzyme stabilizer, miglustat, that&#8217;s
designed to minimize loss of enzyme activity in the blood. In clinical studies, AT-GAA was associated with demonstrated improvements
in both musculoskeletal and respiratory measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>About Pompe
Disease</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Pompe disease is
an inherited lysosomal disorder caused by deficiency of the enzyme acid alpha-glucosidase (GAA). Reduced or absent levels of GAA lead
to accumulation of glycogen in cells, which is believed to result in the clinical manifestations of Pompe disease. Pompe disease ranges
from a rapidly fatal infantile form with significant impacts to heart function, to a more slowly progressive, late-onset form primarily
affecting skeletal muscle and progressive respiratory involvement. Late-onset Pompe disease can be severe and debilitating, including
progressive muscle weakness throughout the body, particularly the skeletal muscles and muscles controlling breathing, that worsens over
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>About&nbsp;Amicus Therapeutics</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Amicus Therapeutics
(Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality
medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding
a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company&#8217;s
website at <U>www.amicusrx.com</U>, and follow on <U>Twitter</U> and <U>LinkedIn</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Forward Looking Statement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529"><FONT STYLE="font-size: 10pt; background-color: white">This
press release contains &quot;forward-looking statements&quot; within the meaning of the Private Securities Litigation Reform Act of 1995,
including statements relating to data from a global Phase 3 open-label extension study to investigate AT-GAA for the treatment of Pompe
and the potential implications on these data for the future advancement and development of AT-GAA, including regulatory submissions for
AT-GAA and the status of those submissions. There can be no assurance that the FDA or EMA will grant approval for AT-GAA. Words such
as, but not limited to, &#8220;look forward to,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221;
 &#8220;intend,&#8221; &quot;confidence,&quot; &quot;encouraged,&quot; &#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;targets,&#8221;
 &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and &#8220;could,&#8221; and similar
expressions or words identify forward-looking statements. The forward-looking statements included in this press release are based on
management's current expectations and belief's which are subject to a number of risks, uncertainties and factors, including that the
Company will not be able to successfully complete the development of, obtain regulatory approval for, or successfully manufacture and
commercialize AT-GAA. In addition, all forward looking statements are subject to the other risks and uncertainties detailed in our Annual
Report on Form 10-K for the year ended December 31, 2021. As a consequence, actual results may differ materially from those set forth
in this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only of the date
hereof. All forward looking statements are qualified in their entirety by this cautionary statement and we undertake no obligation to
revise this press release to reflect events or circumstances after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">CONTACT:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt"><B>Investors:
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Amicus Therapeutics</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Andrew Faughnan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 10pt">Vice
President, Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 10pt"><U>afaughnan@amicusrx.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 10pt">(609)
662-3809</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt"><B>Media:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Amicus Therapeutics</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Diana Moore</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Head of Global
Corporate Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 10pt"><U>dmoore@amicusrx.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">(609) 662-5079</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">FOLD&#8211;G</FONT></P>



<P STYLE="font-size: 10pt; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fold-20230222.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaWMebOdzZR+2YkxtmB2bck6PykhWJxGUSB1LRh2wTIC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:fold="http://amicustherapeutics.com/20230222" elementFormDefault="qualified" targetNamespace="http://amicustherapeutics.com/20230222">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://amicustherapeutics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fold-20230222_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fold-20230222_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>fold-20230222_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>fold-20230222_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://amicustherapeutics.com/role/Cover" xlink:href="fold-20230222.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://amicustherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm237622d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm237622d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ] *@# 2(  A$! Q$!_\0
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MK\Q\1N%N%*N797XE>&\*T>"^(LZSK(JU+$QC]>H8_(U&%&55MSJK*<1[6?\
M8\IU'.7+.,DU=R_2/#GB7BFGG>8\">(./I8KBG+\DRK/<+[-1M5P694U/$7<
M$DZE"\8R5M$VKWB?:=0R*K,,H6.!R".!D_CQ4HZM]?Z"HI<_W]HQR/7DG/\
MD]J_(Y[?PW5U7N))_/7HOU/V63LF_:>R[STT75:]_P! " <[,?4@?GP#4JXQ
MQCKV.:\"_: ^/GPQ_9I^%7BCXR?%_P 02^'?A[X.33)]=U6'3]2U6XMSJ6JV
M>D:>+6PT=)-1O)9M3U"QB:".,KL;<2HWD=5\(/BKX-^-/PX\&_%;X?:H=9\%
M^/=!TWQ/X;U22UGL;B]TG5[.&\LI;JQN42YLKC[/+&LMK<*)X\ R8<E5V6&Q
M:HK$RPDJ6&<O9^VO>/M'M"Z5N9V>G9=U8Y88[!5*_P!5IXV-;$\LI^Q5K\D$
MG*5O[MU?U6Z=SU2BD!R,TM9G6%0NJ^9NZOL  [8RW.._4]N.OM4U?!?_  4&
M_;)T_P#85^ ^J_'74/ &N_$7[/XE\*^%++0=(O8=$T\7GB.[NH5U+Q7XFELM
M:'AWPYIJ0&0ZH^C2)_;4^C:*ERDFO9AZ,)@L=F.+PF RZA]9Q>,Q%+#PHW2<
MHU')3Y;M7DHI6C?77HF<68XW"9=@L1CL;+EP^$@Z\G9OWJ=W'1>=S[I)/"NO
M?(^OT'MCN>WK5B, +QQSS]<"OF;]DS]H+3OVI_V>_AM\>-)\*^*/!.G_ ! T
MN74;;PUXPMD@UK3S::C>Z-=LLR2%=4T6]O=.N;_PQX@$5HGB7PU<Z3X@CL[:
M+4TCKZ7B.=X_NR%?R53_ %J,7A:V!S#%Y=BL++#XC+JLJ%524?<JJ<J=:FK.
M3C*$X.,TI25UN]V8''8;,<)@LQPMG2S"C[6G)-^]!1YD]?\ ),EHHHK([0HH
MHH **** "O%?CQ\5/"WP/^%7Q&^+WC.[BLO#?PX\(:OXQU>>7R@_V'P_;RZI
M+:6QD*YN=6EM8-+M5#,6U"ZL L;N5!]?G8I(I/W6PH=%!DA55FGF9B0<13"W
MBB &#O(/4+C^2'_@XK_;?FDO=&_87\"W4:HT.A>.OC7<VKYCN9IXGU3PGX N
MT1MDFFV$/V;Q_P"(7<,Z:K%\.U41^;,K?9>'W!^*X[XPR/AS"SC16)QM/$8O
M$R^'"Y?@YTJN-KOTHU(T$]+/%Q=U:Z^,\0>*:/!O!^=Y]6_Y<86>'HVZXG%Q
MJTJ"TZ<\6WZ;.]G_ #A_M&_M ?$3]J?XX^-?C;XYNKF[\6>.M=FO+#3[: 2/
MHND).\'@_P +Z:W7^R]%TF:SLANR6M;97;+,2?ZT/^"7_CC]F_\ 8,^ .C>!
MKOP_XVO_ (E>.VTOQO\ %[QA8Z5HT]A_PD4D%I'IO@S2$N]8L-5N=#\!V]['
MHD=O:V\D$5_:ZG+',\\DT<7\R_[&W@G1K?Q-XE^/'CR2UL/ /P;LAJ;WNM'-
MO/XOO(HS9O=<Y\K1DDAU&VX_Y"&J^'CD]J7QR_;(^(?Q0\2SZ=X0U;Q#X"\
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M +GX6_&._P!38ZGI-CK&H:UK^G^&/AG\2K<F&WUZ^NM72/P=,SRM!);,?WK
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MH\JW=CZ\_9X_X*U^%_C%^PY\>/VX?B!\+)_A1X8^!_C37O!3>&;3QNOCB_\
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M#17\QXGGI8BK3<<U?+)I?48P=!+HH\VMUU7W66A_2]"LJ^&PU;_8?WE"G/\
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M@3X:?#JVL]6?PQ\)_B':_%+P?"-3D>5/%5GXIU'Q=!/,RJPO;:+4=8UF06/
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MN9MTXN]XQE'S*_#&18F:F\NI^[5A5?O=8.4EVM\4M%9:NRMH?(7C#]E;X?\
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<Y2LY2=WIIZ*_0^AC&,(QA!6C"*BKZNR5M3__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140442172024848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 22, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 22,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMICUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0869350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3675 Market Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">921-7600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock Par Value $0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FOLD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>tm237622d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fold-20230222.xsd" xlink:type="simple"/>
    <context id="From2023-02-22to2023-02-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178879</identifier>
        </entity>
        <period>
            <startDate>2023-02-22</startDate>
            <endDate>2023-02-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-02-22to2023-02-22">0001178879</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-02-22to2023-02-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-02-22to2023-02-22">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-02-22to2023-02-22">2023-02-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-02-22to2023-02-22">AMICUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-02-22to2023-02-22">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-02-22to2023-02-22">001-33497</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-02-22to2023-02-22">71-0869350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-02-22to2023-02-22">3675 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-02-22to2023-02-22">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-02-22to2023-02-22">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-02-22to2023-02-22">19104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-02-22to2023-02-22">215</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-02-22to2023-02-22">921-7600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-02-22to2023-02-22">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-02-22to2023-02-22">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-02-22to2023-02-22">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-02-22to2023-02-22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-02-22to2023-02-22">Common Stock Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-02-22to2023-02-22">FOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-02-22to2023-02-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-02-22to2023-02-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( '"+5E8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !PBU96KTQ8_>T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TU!(71[6?&D(+B@> N3V=U@TX9DI-VWMXV[740?P&-F_GSS
M#4R#0>,0Z3D.@2([2C>3[_JD,6S$D3EH@(1'\B:5<Z*?F_LA>L/S,QX@&/PP
M!P(EY2UX8F,-&UB 15B)HFTL:HQD>(AGO,45'SYCEV$6@3KRU'."JJQ M,O$
M<)JZ!JZ !<84??HND%V)N?HG-G= G)-3<FMJ',=RK'-NWJ&"MZ?'E[QNX?K$
MID>:?R6G^11H(RZ37^OM_>Y!M$JJNI"J4&JGE%9WNI;OB^L/OZNP'ZS;NW]L
M?!%L&_AU%^T74$L#!!0    ( '"+5E:97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M*G,#7-](J=\'9K=:_K-A_"]02P,$%     @ <(M65I^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '"+5E9U+$JH2@0  '@0   8
M          " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !PBU96GZ ;\+$"  #B#   #0              @ &,#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( '"+5E:7BKL<P    !,"   +
M  "  6@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( '"+5E:JQ"(6,P$  "("
M   /              "  5$0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !PBU96)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !PBU9699!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm237622d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amicustherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm237622d1_8k.htm">tm237622d1_8k.htm</File>
    <File>fold-20230222.xsd</File>
    <File>fold-20230222_lab.xml</File>
    <File>fold-20230222_pre.xml</File>
    <File>tm237622d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm237622d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm237622d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fold-20230222_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fold-20230222_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fold-20230222.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fold",
   "nsuri": "http://amicustherapeutics.com/20230222",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm237622d1_8k.htm",
      "contextRef": "From2023-02-22to2023-02-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://amicustherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm237622d1_8k.htm",
      "contextRef": "From2023-02-22to2023-02-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-23-024366-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-024366-xbrl.zip
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M$*!(!J%FE&^8YBSBXIG7'I>8\8UL#'<S'L,CEIXHMV -*D(3K\Z0@" ;XA-
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M14E4J\0@,+V3;@YE+D7P6>ZQ%90M2L;I$X4Q$+LES=H[#.Q\#5XMAS+,'LI
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M%HT(P1T(X7:(>-X=.B9E0L9"F*R/#4,F/1U0$X%D2O<MJ4L-HGMV)),=R%#
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MUI!BC:3QUU++S%4W&)[.(I")&.*>^7P*X#:93%K<+$O=M/ L <R&-[80EV2
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MDKO>N,36.Q3/FY9+57K\.*&L(%>F+M\X67K_=:]+IN;XM&M[G$>*@AJ>4H:
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M_3&)_P=02P$"% ,4    " !PBU96J#2)B$(#   3#   $0
M@ $     9F]L9"TR,#(S,#(R,BYX<V102P$"% ,4    " !PBU96]_V"=_\*
M  !LAP  %0              @ %Q P  9F]L9"TR,#(S,#(R,E]L86(N>&UL
M4$L! A0#%     @ <(M65AB96XE<!P  U5@  !4              ( !HPX
M &9O;&0M,C R,S R,C)?<')E+GAM;%!+ 0(4 Q0    ( '"+5E;S$?7)!Q,
M "]H   1              "  3(6  !T;3(S-S8R,F0Q7SAK+FAT;5!+ 0(4
M Q0    ( '"+5E:@_Z,D#Q,  %-B   5              "  6@I  !T;3(S
G-S8R,F0Q7V5X.3DM,2YH=&U02P4&      4 !0!' 0  JCP

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
